Theralase Technologies’ (OTC: TLTFF) Therapeutic Laser Technology (“TLT”) division designs, manufactures and markets patented super-pulsed laser technology indicated for the elimination of pain, reduction of inflammation, and dramatic acceleration of tissue healing for numerous nerve, muscle and joint conditions. The company’s Photo Dynamic Therapy (“PDT”) division researches and develops specially designed molecules called Photo Dynamic Compounds (“PDCs”), which are able to localize to cancer cells and then when laser light activated, effectively destroy them. For more information, visit the company’s website at www.theralase.com

Starts Presentation at Marcum MicroCap Conference